Literature DB >> 11918882

A decade of experience with transthoracic and transhiatal esophagectomy.

Michael Bousamra1, George B Haasler, Maryam Parviz.   

Abstract

BACKGROUND: Morbidity and mortality remain significant for transthoracic (TT) and transhiatal (TH) esophagectomy. We report a case-specific approach employing either resection to minimize perioperative morbidity and mortality.
METHODS: All primary esophageal resections performed for benign and malignant esophageal disease were reviewed over a 10-year period. The operative approach was tailored to the location and extent of disease and the physiologic reserve of the patient.
RESULTS: In all, 115 patients underwent esophagectomy for benign (25) and malignant (90) disease. Fifty-six TT and 59 TH resections were performed. Four emergent TT cases did not have reconstruction. There was 1 hospital mortality. Perioperative transfusion was avoided in 65 patients. Respiratory complications occurred in 15. Three patients had a cervical anastomotic leak requiring open wound drainage. No association between resection type and complication was evident.
CONCLUSIONS: The judicious use of both TT and TH esophagectomy resulted in an operative mortality of less than 1%, reduced operative blood loss, and a relatively low rate of perioperative complications.

Entities:  

Mesh:

Year:  2002        PMID: 11918882     DOI: 10.1016/s0002-9610(01)00861-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

Review 1.  Tracheal compression by the gastric tube in esophageal cancer with ankylosing spondylitis and an analysis of the mediastinal condition in 84 cases of esophagectomy: report a case.

Authors:  Norimasa Ikeda; Yasunori Akutsu; Kiyohiko Shuto; Takayuki Tohma; Hisahiro Matsubara
Journal:  Surg Today       Date:  2012-08-04       Impact factor: 2.549

2.  Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.

Authors:  Donald E Low; Sonia Kunz; Drew Schembre; Henry Otero; Tom Malpass; Alex Hsi; Guobin Song; Richard Hinke; Richard A Kozarek
Journal:  J Gastrointest Surg       Date:  2007-08-31       Impact factor: 3.452

3.  Esophagectomy without thoracotomy: 25 years of experience over 750 patients.

Authors:  Panagiotis Yannopoulos; Panagiotis Theodoridis; Konstantinos Manes
Journal:  Langenbecks Arch Surg       Date:  2009-04-07       Impact factor: 3.445

4.  Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability.

Authors:  Ananya Das; Keith M Callenberg; Mindi A Styn; Sara A Jackson
Journal:  Endosc Int Open       Date:  2016-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.